Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Dye & Durham's Fiscal Fourth-Quarter Loss Narrows

Dye & Durham's Fiscal Fourth-Quarter Loss Narrows

MT newswireMT newswire2026/09/29 15:42
11:42 AM EDT, 09/29/2026 (MT Newswires) -- Dye & Durham (DND.TO) shares more than doubled after the company reported a fiscal fourth-quarter loss of CA$19.9 million, compared with a net loss of CA$29.6 million, a year earlier. Revenue fell to CA$104.2 million in the three months ended June 30, compared with CA$105.2 million, a year-ago. Analysts expected revenue of CA$94.9 million, according to FactSet. Excluding the impact of the disposal of Credas Technologies from all periods, revenue increased by CA$3.5 million, or 4%, it said. Shares of the company were last seen up CA$0.525, or 111%, to CA$1.00 on the Toronto Stock Exchange. Price: 1.00, Change: +0.53, Percent Change: +110.53
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials

Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.

智通财经•2026/10/10 06:21